Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.International Journal of Cancer|March 9, 2019
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancerMohamed Elgendy, Juan Pablo Fusco, Victor Segura, et al.Translational Lung Cancer Research|April 23, 2021
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinomaAna Patiño-García, Elizabeth Guruceaga, Victor Segura, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Safety, feasibility and pharmacodynamic activity of intratumoral injections of the agonist anti-CD137 (4-1BB) mAb urelumab in combination with nivolumabMiguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamón, et al.Immunity|April 15, 2020
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune CytotoxicityÁlvaro Teijeira, Saray Garasa, María Gato, et al.Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.Cancer Medicine|May 17, 2018
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancerJuan Pablo Fusco, Guillermo Pita, María José Pajares, et al.Science Translational Medicine|October 15, 2020
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumorsIván Márquez-Rodas, Federico Longo, Maria E Rodriguez-Ruiz, et al.Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|March 5, 2016
Development and Feasibility Testing of a Critical Care EEG Monitoring Database for Standardized Clinical Reporting and Multicenter Collaborative ResearchJong Woo Lee, Suzette LaRoche, Hyunmi Choi, et al.Pageof 20